Human Treatment
Revolutionizing Wound Care
Cold Atmospheric Plasma (CAP) Technology
Introducing our advanced Cold Atmospheric Plasma (CAP) system, a pioneering solution for effective and non-invasive wound healing. Developed by Pacem Technology, our CAP device leverages state-of-the-art Dielectric Barrier Discharge (DBD) plasma technology to address complex wound challenges, promoting rapid tissue regeneration and reducing discomfort without the need for drugs. Our device is designed to significantly improve outcomes in chronic wound care, offering a new standard of treatment for patients facing extensive tissue damage, delayed healing and significant inflammation.
How it works:
Our CAP device utilizes a Dielectric Barrier Discharge (DBD) plasma system to generate cold atmospheric plasma. This plasma, rich in reactive oxygen and nitrogen species (RONS), interacts with the wound bed at a cellular level.
Technical Aspects
- Dielectric Barrier Discharge (DBD) Technology:
This method allows for the generation of stable, low-temperature plasma at atmospheric pressure, ensuring safe application directly to biological tissues. The plasma is generated between two electrodes separated by a dielectric barrier. - Non-Thermal Application:
The “cold” aspect is crucial, as it prevents thermal damage to sensitive tissues, making it suitable for direct application on open wounds. - Precise Application:
The device allows for targeted treatment, focusing the plasma’s therapeutic effects directly on the affected area.
Medical Aspects & Mechanism of Action:
- Antimicrobial Effect:
CAP effectively reduces bacterial load, including antibiotic-resistant strains, preventing and combating infections that often impede wound healing. - Inflammation Reduction:
By modulating inflammatory responses, CAP helps to decrease severe inflammation and exudate, creating a more conducive environment for healing. - Promotes Granulation Tissue Formation:
The plasma stimulates the proliferation of fibroblasts and keratinocytes, leading to early and robust granulation tissue formation, essential for wound closure. - Enhanced Re-epithelialization:
CAP accelerates the migration and proliferation of epithelial cells, facilitating faster re-epithelialization and improved skin integrity. - Improved Blood Circulation:
CAP application can enhance microcirculation in the wound area, delivering vital nutrients and oxygen for tissue repair. - Pain Reduction:
Patients often experience decreased pain, contributing to a more comfortable healing process.
Clinical Benefits & Results
Cold Atmospheric Plasma (CAP) device has demonstrated remarkable efficacy in clinical settings, as evidenced by a severe pressure ulcer case study. The results highlight its potential as a promising non-invasive therapy for chronic wound care.
Key Clinical Observations
- Rapid Bacterial Load Reduction:
Significant decrease in bacterial presence observed within the first week of treatment. - Effective Inflammation Control:
Severe inflammation and exudate were notably reduced, paving the way for healthy tissue regeneration. - Accelerated Granulation and Epithelialization:
Consistent daily application led to early granulation tissue formation, increased coverage of the ulcer and significant re-epithelialization by the end of three weeks. - Prevention of Necrotic Progression:
No further necrotic tissue progression was observed after treatment initiation, with existing necrotic tissue showing signs of healing. - Improved Wound Contraction & Skin Integrity:
The treatment promoted healthy wound contraction and improved overall skin integrity, leading to a near-complete coverage of the wound bed with healthy granulation tissue. - No Infection or Complications:
The treatment regimen ensured a sterile healing environment, with no observed infections or complications throughout the therapy.
Summary of Clinical Efficacy
Cold Atmospheric Plasma applied via our DBD system effectively promoted healing in severe pressure ulcers. It successfully reduced inflammation, prevented infection, and accelerated tissue regeneration, offering a safe, painless, and drug-free alternative for complex wound management.
Why Choose Our CAP Technology?
- Non-Invasive & Painless:
Offers a comfortable treatment experience without the need for surgical intervention or painful procedures. - Drug-Free Healing:
Achieves significant therapeutic outcomes without reliance on pharmaceuticals, reducing potential side effects and costs. - Comprehensive Wound Management:
Addresses multiple aspects of wound healing – infection control, inflammation reduction and tissue regeneration. - Rapid & Visible Results:
Patients experience noticeable improvements in wound conditions from the first week of treatment. - Safe & Reliable:
Backed by robust R&D and clinical observations, ensuring a safe and effective treatment modality.